Cargando…
Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice
Obesity and its related metabolic abnormalities, including enhanced oxidative stress and chronic inflammation, are closely related to colorectal tumorigenesis. Pentoxifylline (PTX), a methylxanthine derivative, has been reported to suppress the production of tumor necrosis factor (TNF)-α and possess...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343947/ https://www.ncbi.nlm.nih.gov/pubmed/28212276 http://dx.doi.org/10.3390/ijms18020413 |
_version_ | 1782513460596178944 |
---|---|
author | Fukuta, Kazufumi Shirakami, Yohei Maruta, Akinori Obara, Koki Iritani, Soichi Nakamura, Nobuhiko Kochi, Takahiro Kubota, Masaya Sakai, Hiroyasu Tanaka, Takuji Shimizu, Masahito |
author_facet | Fukuta, Kazufumi Shirakami, Yohei Maruta, Akinori Obara, Koki Iritani, Soichi Nakamura, Nobuhiko Kochi, Takahiro Kubota, Masaya Sakai, Hiroyasu Tanaka, Takuji Shimizu, Masahito |
author_sort | Fukuta, Kazufumi |
collection | PubMed |
description | Obesity and its related metabolic abnormalities, including enhanced oxidative stress and chronic inflammation, are closely related to colorectal tumorigenesis. Pentoxifylline (PTX), a methylxanthine derivative, has been reported to suppress the production of tumor necrosis factor (TNF)-α and possess anti-inflammatory properties. The present study investigated the effects of PTX on the development of carcinogen-induced colorectal premalignant lesions in obese and diabetic mice. Male C57BL/KsJ-db/db mice, which are severely obese and diabetic, were administered weekly subcutaneous injections of the colonic carcinogen azoxymethane (15 mg/kg body weight) for four weeks and then received drinking water containing 125 or 500 ppm PTX for eight weeks. At the time of sacrifice, PTX administration markedly suppressed the development of premalignant lesions in the colorectum. The levels of oxidative stress markers were significantly decreased in the PTX-treated group compared with those in the untreated control group. In PTX-administered mice, the mRNA expression levels of cyclooxygenase (COX)-2, interleukin (IL)-6, and TNF-α, and the number of proliferating cell nuclear antigen (PCNA)-positive cells in the colonic mucosa, were significantly reduced. These observations suggest that PTX attenuated chronic inflammation and oxidative stress, and prevented the development of colonic tumorigenesis in an obesity-related colon cancer model. |
format | Online Article Text |
id | pubmed-5343947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53439472017-03-16 Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice Fukuta, Kazufumi Shirakami, Yohei Maruta, Akinori Obara, Koki Iritani, Soichi Nakamura, Nobuhiko Kochi, Takahiro Kubota, Masaya Sakai, Hiroyasu Tanaka, Takuji Shimizu, Masahito Int J Mol Sci Article Obesity and its related metabolic abnormalities, including enhanced oxidative stress and chronic inflammation, are closely related to colorectal tumorigenesis. Pentoxifylline (PTX), a methylxanthine derivative, has been reported to suppress the production of tumor necrosis factor (TNF)-α and possess anti-inflammatory properties. The present study investigated the effects of PTX on the development of carcinogen-induced colorectal premalignant lesions in obese and diabetic mice. Male C57BL/KsJ-db/db mice, which are severely obese and diabetic, were administered weekly subcutaneous injections of the colonic carcinogen azoxymethane (15 mg/kg body weight) for four weeks and then received drinking water containing 125 or 500 ppm PTX for eight weeks. At the time of sacrifice, PTX administration markedly suppressed the development of premalignant lesions in the colorectum. The levels of oxidative stress markers were significantly decreased in the PTX-treated group compared with those in the untreated control group. In PTX-administered mice, the mRNA expression levels of cyclooxygenase (COX)-2, interleukin (IL)-6, and TNF-α, and the number of proliferating cell nuclear antigen (PCNA)-positive cells in the colonic mucosa, were significantly reduced. These observations suggest that PTX attenuated chronic inflammation and oxidative stress, and prevented the development of colonic tumorigenesis in an obesity-related colon cancer model. MDPI 2017-02-15 /pmc/articles/PMC5343947/ /pubmed/28212276 http://dx.doi.org/10.3390/ijms18020413 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fukuta, Kazufumi Shirakami, Yohei Maruta, Akinori Obara, Koki Iritani, Soichi Nakamura, Nobuhiko Kochi, Takahiro Kubota, Masaya Sakai, Hiroyasu Tanaka, Takuji Shimizu, Masahito Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title | Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title_full | Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title_fullStr | Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title_full_unstemmed | Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title_short | Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice |
title_sort | preventive effects of pentoxifylline on the development of colonic premalignant lesions in obese and diabetic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343947/ https://www.ncbi.nlm.nih.gov/pubmed/28212276 http://dx.doi.org/10.3390/ijms18020413 |
work_keys_str_mv | AT fukutakazufumi preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT shirakamiyohei preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT marutaakinori preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT obarakoki preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT iritanisoichi preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT nakamuranobuhiko preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT kochitakahiro preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT kubotamasaya preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT sakaihiroyasu preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT tanakatakuji preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice AT shimizumasahito preventiveeffectsofpentoxifyllineonthedevelopmentofcolonicpremalignantlesionsinobeseanddiabeticmice |